Testing a new medication to help prevent leukemia relapse after blood cell transplant

This trial is testing whether mocravimod, a new medication, can help prevent acute myeloid leukemia from coming back after you receive a blood cell transplant from a donor. You would take this medication by mouth once a day for 12 months while your body recovers from the transplant. The study compares two different doses of the medication against a placebo (a pill with no active ingredient) to see which works best and is safest.

Acute myeloid leukemia is a serious blood cancer, and even after a successful blood cell transplant, the disease can return. Researchers believe this medication might help prevent that relapse and improve survival, but they need to test it in a large, carefully controlled study to be sure it works and is safe.